ArticleLancet regional health. Americas2023

Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083.

Kate M Mitchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.